hsa-mir-4730 _LIHC.png
BACE2 _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10020443
Fusion event
HBV-BACE2 integration
Validated
No
Detection method
VirusScan
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Good
Reported year
2016
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Start
1150
End
2250
Orient
+
Integrated sequence
TTGCCCGGCAACGGTCAGGTCTCTGCCAAGTGTTTGCTGACGCAACCCCCACGGGTTGGGGCTTGGCCATAGGCCATCGGCGCATGCGTGGAACCTTTGTGGCTCCTCTGCCGATCCATACTGCGGAACTCCTAGCAGCTTGTTTTGCTCGCAGCCGGTCTGGAGCGAAACTTATCGGAACCGACAACTCAGTTGTCCTCTCTCGGAAATACACCTCCTTTCCATGGCTGCTAGGCTGTGCTGCCAACTGGATCC
Host Sequence
Chromosome
chr21
Cytoband
q22.3
Reference genome
End
42594022/41222095 (Hg38)
Orient
-
Location type
Intronic
Target gene
miRNAs that regulate target gene
hsa-mir-484 ; hsa-mir-2054 ; hsa-mir-1299 ; hsa-mir-3686 ; hsa-mir-4662a-5p ; hsa-mir-5189-3p ; hsa-mir-3607-3p ; hsa-mir-4778-5p ; hsa-mir-3651 ; hsa-mir-1277-5p ; hsa-mir-302c-5p ; hsa-mir-6739-5p ; hsa-mir-3153 ; hsa-mir-6733-5p ; hsa-mir-211-3p ; hsa-mir-7845-5p ; hsa-mir-5584-5p ; hsa-mir-6859-5p ; hsa-mir-3916 ; hsa-mir-3125 ; hsa-mir-583 ; hsa-mir-6868-3p ; hsa-mir-670-5p ; hsa-mir-2277-3p ; hsa-mir-3667-3p ; hsa-mir-6734-3p ; hsa-mir-4319 ; hsa-mir-125b-5p ; hsa-mir-125a-5p ; hsa-mir-4732-3p ; hsa-mir-345-3p ; hsa-mir-1207-3p ; hsa-mir-141-5p ; hsa-mir-4526 ; hsa-mir-3660 ; hsa-mir-498 ; hsa-mir-4279 ; hsa-mir-525-5p ; hsa-mir-520a-5p ; hsa-mir-1976 ; hsa-mir-3653-5p ; hsa-mir-6747-3p ; hsa-mir-6727-3p ; hsa-mir-4722-3p ; hsa-mir-1303 ; hsa-mir-5096 ; hsa-mir-3149 ; hsa-mir-3912-5p ; hsa-mir-197-3p ; hsa-mir-411-5p ; hsa-mir-6755-3p ; hsa-mir-198 ; hsa-mir-6832-5p ; hsa-mir-193b-5p ; hsa-mir-4716-5p ; hsa-mir-4673 ; hsa-mir-4645-5p ; hsa-mir-483-5p ; hsa-mir-6848-3p ; hsa-mir-6843-3p ; hsa-mir-378a-5p ; hsa-mir-6131 ; hsa-mir-3663-5p ; hsa-mir-372-5p ; hsa-mir-371a-5p ; hsa-mir-616-5p ; hsa-mir-373-5p ; hsa-mir-371b-5p ; hsa-mir-874-3p ; hsa-mir-3157-3p ; hsa-mir-4448 ; hsa-mir-6861-3p ; hsa-mir-6821-3p ; hsa-mir-3182 ; hsa-mir-149-5p ; hsa-mir-4794 ; hsa-mir-664a-5p ; hsa-mir-1236-3p ; hsa-mir-6515-3p ; hsa-mir-1248 ; hsa-mir-1237-3p ; hsa-mir-4723-3p ; hsa-mir-6769b-3p ; hsa-mir-3183 ; hsa-mir-6800-3p ; hsa-mir-3064-5p ; hsa-mir-6504-5p ; hsa-mir-1226-5p ; hsa-mir-25-5p ; hsa-mir-3616-3p ; hsa-mir-433-5p ; hsa-mir-4487 ; hsa-mir-4710 ; hsa-mir-4721 ; hsa-mir-4730 ; hsa-mir-553 ; hsa-mir-7160-3p
Nearest miRNA
hsa-let-7c/Upstream/53416; hsa-mir-5692b/Downstream/524677;
Upstream sequence
gcactttgggaggctgaggcgggtggatcacttgaagtcaggagttcaagaccagcctgggcaacacagtgagaccccatctcaaaaaaaaagtatatta
Downstream sequence
gttgagcaagtcagactctctgcacctcagtgtttgcatctgtgacgtggagtgaggactgtgctgccctcagagctctgttatgaggttgaaataagct
Target sequence
aaaaaaaAAAAAAAAAACAGTAGAGTGCCTTTGCCATTGTTTTAGATTCACTTCAAACCTTCATCCCCCAAATCTGTTTCCCTACCATTCCTACAAAGTTTTTGTGAACATGATCTTCATTGGTCGGGAGGGAATTCTCTGAAGTCACAAAGTAGCTTTTCGTTTGAGAAAACACAGGGGTGTGACCACAGGTTACAGCACTGCCCCTGGCAGATGCCCAGGACTGTCGTTCATTCCTCTCCACTATTTCCATGG
Reference
Cao, S., et al.Divergent viral presentation among human tumors and adjacent normal tissues. Sci Rep,2016, 6: 28294.
Curate